Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs D Naber, S Moritz, M Lambert, F Rajonk, R Holzbach, R Mass, ... Schizophrenia research 50 (1-2), 79-88, 2001 | 482 | 2001 |
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges WW Fleischhacker, M Cetkovich-Bakmas, M De Hert, CH Hennekens, ... Journal of Clinical Psychiatry 69 (4), 514, 2008 | 466 | 2008 |
The impact of substance use disorders on clinical outcome in 643 patients with first‐episode psychosis M Lambert, P Conus, DI Lubman, D Wade, H Yuen, S Moritz, D Naber, ... Acta Psychiatrica Scandinavica 112 (2), 141-148, 2005 | 418 | 2005 |
Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence M Lambert, P Conus, P Eide, R Mass, A Karow, S Moritz, D Golks, ... European Psychiatry 19 (7), 415-422, 2004 | 375 | 2004 |
Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis SM Cotton, M Lambert, BG Schimmelmann, DL Foley, KI Morley, ... Schizophrenia research 114 (1-3), 17-24, 2009 | 239 | 2009 |
Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life M Lambert, D Naber CNS drugs 18 (Suppl 2), 5-17, 2004 | 234 | 2004 |
Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later M Lambert, A Karow, S Leucht, BG Schimmelmann, D Naber Dialogues in clinical neuroscience 12 (3), 393-407, 2010 | 232 | 2010 |
Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients BG Schimmelmann, P Conus, S Cotton, PD McGorry, M Lambert Schizophrenia research 95 (1-3), 1-8, 2007 | 232 | 2007 |
Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort BG Schimmelmann, CG Huber, M Lambert, S Cotton, PD McGorry, ... Journal of psychiatric research 42 (12), 982-990, 2008 | 216 | 2008 |
Rates and predictors of remission and recovery during 3 years in 392 never‐treated patients with schizophrenia M Lambert, D Naber, A Schacht, T Wagner, HP Hundemer, A Karow, ... Acta Psychiatrica Scandinavica 118 (3), 220-229, 2008 | 212 | 2008 |
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. P McGorry Australian & New Zealand Journal of Psychiatry 39, 2005 | 211 | 2005 |
Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia M Lambert, BG Schimmelmann, D Naber, A Schacht, A Karow, T Wagner, ... Journal of Clinical Psychiatry 67 (11), 1690-1697, 2006 | 210 | 2006 |
Pretreatment and outcome correlates of sexual and physical trauma in an epidemiological cohort of first-episode psychosis patients P Conus, S Cotton, BG Schimmelmann, PD McGorry, M Lambert Schizophrenia bulletin 36 (6), 1105-1114, 2010 | 190 | 2010 |
The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians D Naber, M Lambert CNS drugs 23, 649-659, 2009 | 187 | 2009 |
Diagnostic stability 18 months after treatment initiation for first-episode psychosis BG Schimmelmann, P Conus, J Edwards, PD McGorry, M Lambert Journal of Clinical Psychiatry 66 (10), 1239-1246, 2005 | 185 | 2005 |
Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review MT Samara, C Leucht, MM Leeflang, IG Anghelescu, YC Chung, ... American journal of psychiatry 172 (7), 617-629, 2015 | 166 | 2015 |
Rate and predictors of service disengagement in an epidemiological first-episode psychosis cohort P Conus, M Lambert, S Cotton, C Bonsack, PD McGorry, ... Schizophrenia research 118 (1-3), 256-263, 2010 | 166 | 2010 |
Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first-and multiple-episode schizophrenia spectrum disorders … M Lambert, T Bock, D Schöttle, D Golks, K Meister, L Rietschel, ... The Journal of clinical psychiatry 71 (10), 1421, 2010 | 166 | 2010 |
Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. A Karow, J Czekalla, RW Dittmann, A Schacht, T Wagner, M Lambert, ... Journal of Clinical Psychiatry 68 (1), 75-80, 2007 | 160 | 2007 |
Subjective well‐being under neuroleptic treatment and its relevance for compliance D Naber, A Karow, M Lambert Acta Psychiatrica Scandinavica 111, 29-34, 2005 | 146 | 2005 |